Harpoon Therapeutics Inc (HARP)
NASDAQ:HARP
Holding HARP?
Track your performance easily

Harpoon Therapeutics (HARP) Stock Investors

452 Followers
Based on 720,730 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold HARP
On average, investors allocate 0.00% of their portfolios to HARP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 720,730 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding HARP

2.8%
Last 7
Days
1.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding HARP, out of 720,730 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

HARP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$6.64
Based on the activity of 13,507 investors who made their portfolios public
The table shows changes in HARP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

HARP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.10%
+0.88%
+2.62%
36.07B
Consumer Cyclical
Micron
5.39%
+1.19%
+9.14%
104.33B
Technology
Assertio Therapeutics
2.66%
-1.12%
-4.53%
88.49M
Healthcare
Riot Platforms
4.95%
-0.18%
+4.72%
2.99B
Financial
Merck & Company
4.05%
-0.27%
+1.78%
310.93B
Healthcare
Coherus Biosciences
2.60%
-1.28%
-4.42%
252.80M
Healthcare
Marathon Digital Holdings
5.65%
+0.32%
+8.76%
5.52B
Financial
ChargePoint Holdings
3.95%
-1.23%
-2.42%
802.61M
Consumer Cyclical
Marvell
4.82%
+2.09%
+5.48%
62.56B
Technology
Mercadolibre
5.39%
+0.37%
+7.83%
78.45B
Consumer Cyclical
Based on the activity of 720,730 active portfolios
Open your Smart Portfolio

HARP Investor Analysis

HARP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.2%
of HARP holders
are under 35
Average Segment Performance
Average P/E Ratio57.88
Beta7.28
Dividend Yield5.79%
HARP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
46.2%
of HARP holders
are between 35–55
Average Segment Performance
Average P/E Ratio63.54
Beta11.04
Dividend Yield6.78%
HARP investors over 55

Over 55

4.1%
Last 30 days
Holdings Change
44.5%
of HARP holders
are over 55
Average Segment Performance
Average P/E Ratio54.91
Beta5.67
Dividend Yield5.91%
Overview of age group and performance of HARP stock investors
See who invests in HARP according to age group and performance.

FAQ

How many retail Investors hold HARP?
<0.1% of TipRanks' retail investors hold HARP in their portfolios.
    What is HARP Investor Sentiment?
    HARP’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of HARP in the last 7 days?
      ▼ 2.8% of TipRanks' retail investors changed their holding of HARP in the last 7 days.
        What percentage of retail investors changed their holding of HARP in the last 30 days?
        ▲ 1.5% of TipRanks' retail investors changed their holding of HARP in the last 30 days.
          What is the average age of retail investors who hold HARP?
          The average age of HARP Holders is between 35–55.
            What other stocks have HARP investors also bought?
            HARP Investors also bought DKNG, MU, ASRT, RIOT, MRK, CHRS, MARA, CHPT, MRVL, MELI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ALNYAlnylam Pharma
              ATECAlphatec Holdings
              BCRXBioCryst
              CAHCardinal Health
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis